US-based enterprise telehealth company Caregility has entered a strategic reseller collaboration with MOD3RN Care for expediting virtual care and AI-enabled care models implementation in Australia.
This partnership aims to improve clinical capacity, patient safety and alleviate staff burnout across Australia.
MOD3RN Care will distribute the Connected Care Platform and edge AI devices of Caregility to hospitals and health systems in the region.
These products will support them as they implement secure virtual care schemes across outpatient, inpatient, long-term care and home environments.
MOD3RN Care CEO Nicholas Rorris said: “Australia's health systems are facing many of the same workforce challenges the US experienced during and following the pandemic.
“Caregility's Connected Care Platform and Virtual Nursing workflows have demonstrated how technology can extend nurses' reach, ease workloads, and deliver safer, more consistent care.
“Together, we're helping Australian hospitals augment, not replace, clinicians with intelligent tools that add more care minutes to their day.”
The Connected Care Platform supports a full suite of clinical workflows, including virtual observation, virtual nursing and multi-speciality virtual consults.
This platform, which leverages integrated edge AI devices and sensors to enhance care efficiency, has been deployed across more than 1,100 hospitals worldwide.
It integrates with Epic EHR and features proactive device monitoring and remote updates, maintaining uptime performance above 99%.
To comply with Australian data sovereignty and privacy laws, Caregility will localise hosting within the country’s data centres.
Caregility president and COO Mike Brandofino said: “Virtual and AI-supported care models are becoming a cornerstone of modern healthcare delivery globally.
“Partnering with MOD3RN Care gives us a trusted onshore collaborator to help Australian providers tap into proven models that improve staff efficiency and patient outcomes.”
In September 2025, Caregility raised $25.1m in additional funding through Series A-2 and Series C rounds to expand its virtual care technology.
